Keywords: syntaxin, allergan, sign, second, deal, salisbury, uk-based

Syntaxin and Allergan sign second R&D deal

Article | 11 September 2006

Salisbury, UK-based drug development firm Syntaxin has entered into a second exclusive research and license arrangement with US group Allergan ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Allergan

Go to company listing